8 mg per week Resulted in substantial body weight decreases, suggesting it may offer an optimal balance between efficacy and tolerability
Some health insurers cover GLP-1s for people who are most at risk of serious disease, for example those with a BMI over 40
Semaglutide, the active ingredient in both Ozempic and Wegovy, has a demonstrated correlation with pancreatitis, acute kidney injury, and non-arteritic anterior ischemic optic neuropathy (NAION), which can cause blindness
To achieve lasting results, weight loss medications are most effective when combined with a healthy diet, regular physical activity, and lifestyle interventions
Ingredient sourcing For safety, a compounding pharmacy should use FDA-registered active pharmaceutical ingredients (APIs)